Donanemab and another new drug for Alzheimer’s called Lecanemab have been billed as a huge step forward in research ...

Donanemab, the most effective treatment yet for the disease, has been banned on the health service despite regulators ...

Diagnosed with mild cognitive impairment (MCI) in 2018, Mr Almond, from Esher, took part in two 18-month trials for donanemab ...

The UK’s National Institute of Health and Care Excellence (NICE) said the drug provided only a small benefit to patients.

The Alzheimer's Society Cymru has responded to the approval of a new Alzheimer's treatment. The Medicines and Healthcare products Regulatory Agency (MHRA) announced on Wednesday, October 23, that it ...

Health spending watchdog said costs could not justify benefits after treatment slowed cognitive decline by around four to ...

The Dementia Trials Accelerator (DTA) – which will be spearheaded by the UK Dementia Research Institute (UK DRI) and Health ...

A dad-of-eight who became an “icon” through his 13 years working at Poundland has tragically died the night before a landmark birthday. Devastated family pay tribute to son, 25, who was ...

The service began in 1999, and received a significant boost in 2009 when it won the contract to supply the IRN network of radio stations. More than 280 stations make up the network, including well ...

Oct. 23, 2024 — Until now, researchers have been limited in developing photonic memory for AI processing -- gaining one important attribute like speed while sacrificing another like energy usage ...